Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06034080

Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections

This study aims to improve care and reduce unnecessary antibiotic prescribing for children with ear infections. The study will compare the effectiveness of a "gold standard" to a hybrid intervention combined with this gold standard, in order to identify steps to increase parent satisfaction for child ear infection care. The "gold standard" approach is a Health System Level Intervention. On its own, it involves clinician education, tools in electronic medical records, and audit and feedback reports for clinician prescribing habits. The hybrid intervention includes the elements of the health systems level intervention in addition to a Shared Decision-Making component, which allows for both an increase in the role parents play in their child's care, as well as clinician education for how to use this method. The goals of this work are to increase parent satisfaction, reduce antibiotics taken for childhood ear infections, align medical care with the current national guidelines, and evaluate differences in the two intervention groups. Both groups will be evaluated for implementation outcomes to improve dissemination and scalability for future use of these models in antibiotic prescribing for children with ear infections.

This study will recruit a diverse group of patients and clinicians to complete surveys, parents to participate in focus groups, and clinicians and administrators to be interviewed in order to meet study aims and receive sufficient feedback on the interventions performed. There are two hypotheses for this research: 1. The Hybrid Intervention will have higher parent satisfaction and reduced antibiotic use compared to the Health-System Level Intervention and 2. The Hybrid Intervention will be more challenging to implement than the Health-System Level Intervention, but will be preferred by parents, clinicians, and administrators.

Recruiting

Interested in participating?

Request Info

Key information

Age range

6 month–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Denver Health and Hospital Authority, Denver, Colorado, United States

Loading trial locations.

About this study

Acute otitis media (AOM), commonly referred to as an ear infection, is the most common reason children are prescribed antibiotics, affecting 5 million children and resulting in 10 million antibiotic prescriptions annually. By 3 years of age over 60% of children will have had AOM. Though 84% of AOM episodes resolve without antibiotics, antibiotics are prescribed to >95% of children. The American Academy of Pediatrics (AAP) recommends that most children with AOM do not receive an immediate antibiotic (an antibiotic to take right away) and instead be managed with watchful waiting, where an antibiotic is used only if the child worsens or does not improve. In clinical trials watchful waiting reduced antibiotic use by over 62% and did not result in increased complications, reduced parent satisfaction, or increased symptoms. Unfortunately, despite these trials <5% of children with AOM are managed with watchful waiting. The use of antibiotics when not needed contributes to the development of antibiotic resistant organisms, which makes future infections more difficult to treat. Additionally, unnecessary antibiotics reduce pediatric quality of life and over 26% of children who take an antibiotic experience an adverse drug event (ADE). Thus, for every 100 children with AOM who take an antibiotic at least 26 children experience harm; whereas only 5 children have symptomatic benefit.

This study aims to compare the effectiveness of two pragmatic interventions to improve patient-centered outcomes and reduce unnecessary antibiotics taken for AOM. Interventions will be conducted at 33 community-based clinics and/or urgent care centers across three distinct geographic regions in the United States. Randomization will occur at the clinic center level to either the gold standard approach or the hybrid intervention. The Practical Robust Implementation and Sustainability Model (PRISM) will be used to guide implementation and the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) framework will be used to evaluate outcomes. A mixed-methods approach will be used in the pre-implementation and evaluation phases and will utilize quantitative analyses, semi-structured interviews, focus groups, and surveys.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

A. Implementation of Interventions 1. Clinic at a participating organization 2. Provides care to children with AOM 3. Administrative or local approval for participation

B. Secondary Electronic Health Record Data

  • Aged 6 months-17-years-old (inclusive)
  • Diagnosis of AOM by ICD10 code

C. Video recordings or direct observation of the use of a shared decision aid

Parent participation:

  • Child aged 6 months-17 years (inclusive)
  • Diagnosed with AOM by clinician
  • Parent or legal guardian is present and is >=18 years or older

Clinician Participation:

  • Licensed clinician and not a medical trainee
  • Age 18 >= years or older

D. Pre-implementation interviews of clinicians and administrators

  • Licensed clinician (physician or advanced practice clinician) that cares for children with AOM at a participating organization or an administrator/manager at a participating organization.
  • Aged >=18 years-no maximum

E. Pre-implementation focus groups of parents

  • Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization.
  • 18 years of age or older and able/willing to consent

F. Parents enrolled for surveys

  • Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization. 2. Willing to participate and able to complete electronic surveys at enrollment and 10 days after enrollment. 3. Working phone 4. Age >=18 years of age

G. Post-intervention focus groups of parents

  • Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization.
  • 18 years of age or older and able/willing to consent

H. Post-intervention surveys of clinicians and administrators

  • Licensed clinician (physician or advanced practice clinician) that cares for children with AOM at a participating organization or an administrator/manager at a participating organization.
  • Aged >=18 years-no maximum

Exclusion criteria

A. Implementation of Interventions

  • Clinics that exclusively provide telehealth

B. Secondary Electronic Health Record Data

  • None

C. Video recordings or direct observation of the use of a shared decision aid

Parent participation:

  • None

Clinician Participation:

  • None

D. Pre-implementation interviews of clinicians and administrators 1. Medical trainee (student, resident, fellow, etc.)

E. Pre-implementation focus groups of parents

  • None

F. Parents enrolled for surveys 1. Complicated or recurrent AOM as determined by the study team

G. Post-intervention focus groups of parents 1. None

H. Post-intervention surveys of clinicians and administrators

  • Medical trainee (student, resident, fellow, etc.)

Treatment and study plan

Changes to the electronic health record (EHR)

Other

EHR changes will include minor changes to prescription fields to make it easier for clinicians to order "wait and see" antibiotics to be filled only if the child worsens or does not improve rather than antibiotics to take immediately.

Individualized audit and feedback reporting for clinicians

Other

Automated audit and feedback reports detailing participating clinicians' antibiotic prescribing habits for AOM both individually and in comparison to their peers will be shared with clinicians on a quarterly basis throughout the intervention period.

Clinician education sessions

Other

Virtual education sessions will be held for clinicians to learn more about national guidelines for antibiotic prescribing for AOM, etc. The sessions will be recorded and distributed to clinicians who were unable to attend. Attendance of these sessions will apply toward continuing medical education credits for participants.

Use of a shared decision-making (SDM) aide

Other

A previously validated SDM aide for AOM will be used by clinicians during visits with children with AOM. The aide will be available online and in paper form.

Shared decision-making (SDM) education

Other

Clinicians will receive education on SDM and how to use the aid via virtual, recorded sessions.

Primary outcomes

  1. Increase in Parent Satisfaction

    Time frame: 10 days after clinic visit for ear infection

    Survey responses will be measured by the percentage of "Very Satisfied" or "Extremely Satisfied" responses from parents on a 7-point Likert Scale. The survey tool will be created from adaptations to the Pediatric Quality of Life Inventory (PedsQL) and the Acute Otitis Media Severity of Symptom Scale (AOM-SOS). In this survey, the higher scores on the Likert Scale will indicate more overall parent satisfaction.

  2. Percentage of Patients Taking an Antibiotic for AOM

    Time frame: 10 days after clinic visit for ear infection

    Comparing electronic health record prescription data with parent yes/no survey responses to a question on whether or not their child took an antibiotic prescribed for treating their ear infection.

Secondary outcomes

  1. Shared Decision-Making

    Time frame: At time of clinic visit for ear infection (0 Days)

    Summed score of the "Knowledge and Decisional Conflict Assessment" section of the Shared Decision-Making Questionnaire (SDM Q-9). The survey has a 6-Point Likert Scale ranging in values from "Completely Disagree" to "Completely Agree". For this survey, the higher the number on the Likert Scale, the better the outcome.

  2. Pediatric Quality of Life

    Time frame: 10 days after clinic visit for ear infection

    Score on the PEDS-QL Survey. This survey has a 5-Point Likert Scale ranging from "Never a Problem" (0 points) to "Almost Always a Problem" (4 points). Higher scores on this scale indicate worse outcomes while lower scores indicate better outcomes.

  3. Symptom and Severity Duration

    Time frame: 0 and 10 days after clinic visit for ear infection

    Scores on a Likert scale from the AOM-Severity of Symptom scale survey on the following measures:

    • Symptom Severity (at maximum and at 10 days)
    • Time to Symptom Improvement (from onset)
    • Time to All Symptom Resolution (from onset)
    • Time to Ear Pain Resolution (from onset)
    • Symptoms Resolved at Day 10 (yes/no)
  4. Missed Work/School/Daycare

    Time frame: 10 days after clinic visit for ear infection

    Numbers of days child missed school/daycare and/or number of days parent(s) missed work

  5. Adverse Drug Events

    Time frame: 10 days after clinic visit for ear infection

    Percentage of patients with adverse drug event(s)

  6. Treatment Failure

    Time frame: 10 days after clinic visit for ear infection

    Percentage that changed their medication management (i.e., took an antibiotic if initially trying watchful waiting or tried a new antibiotic if initially immediately tried antibiotics)

  7. Management Strategy

    Time frame: At time of clinic visit for ear infection (0 Days)

    Percentage of immediate antibiotic use

  8. Antibiotic Prescription Filled

    Time frame: 10 days after clinic visit for ear infection

    Percentage of filled antibiotic prescriptions (even if not taken)

Study contacts

Contact information is provided by the study sponsor or research team.

Holly M Frost, MD

CONTACT

[email protected]

715-437-0270

Theresa L Morin, MA

CONTACT

[email protected]

802-881-9534

Sponsors and collaborators

Lead sponsor

Intermountain Health Care, Inc.

Other

Collaborators

  • AllianceChicago
  • Denver Health and Hospital Authority
  • Mayo Clinic
  • Patient-Centered Outcomes Research Institute

Registry information

Official study title

DISAPEAR Trial: Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections

Acronym: DISAPEAR

Important dates

Study start
2025
Primary completion
2027
Study completion
2029
First posted
Sep 13, 2023
Registry last updated
Sep 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.